— Know what they know.
Not Investment Advice
Also trades as: AVE.AX (ASX) · $vol 0M

AVEFF OTC

Avecho Biotechnology Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -10.0% 5Y: -10.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 52 · $17.4M mcap · 3.18B float · 0.0062% daily turnover · Short 100% of daily vol

Balance Sheet Trends

Total Assets
$7M +42.2% ▲
5Y CAGR: +16.2%
Total Liabilities
$6M +221.0% ▲
5Y CAGR: +51.3%
Shareholders Equity
$2M -52.3% ▼
5Y CAGR: -10.1%
Cash & Investments
$5M +96.3% ▲
5Y CAGR: +20.0%
Total Debt
$14K -98.7% ▼
5Y CAGR: -38.6%
Net Debt
-$5M -258.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$3M$1M$6M$2M$5M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$3M$1M$6M$2M$5M
Net Receivables$1M$0$1M$2M$2M
Inventory$197K$402K$97K$137K$8K
Other Current Assets$1M$0$0$52K$180K
Total Current Assets$5M$3M$7M$5M$7M
Property, Plant & Equip.$336K$468K$316K$171K$34K
Goodwill & Intangibles$102K$26K$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$16K$16K
Total Non-Current Assets$438K$494K$316K$187K$49K
Total Assets$5M$3M$7M$5M$7M
— Liabilities —
Accounts Payable$75K$191K$95K$61K$104K
Short-Term Debt$0$0$0$978K$14K
Deferred Revenue$0$0$158K$0$0
Other Current Liabilities$122K$24K$24K$435K$95K
Total Current Liabilities$696K$746K$843K$2M$709K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$2K$4K
Total Non-Current Liabilities$14K$175K$98K$17K$5M
Total Liabilities$709K$921K$942K$2M$6M
— Equity —
Common Stock$238M$238M$245M$245M$247M
Retained Earnings-$262M-$264M-$267M-$269M-$246M
Accumulated OCI$29M$29M$29M$28M$654K
Total Stockholders Equity$5M$2M$6M$3M$2M
Total Liabilities & Equity$5M$3M$7M$5M$7M
— Key Metrics —
Total Debt$94K$246K$175K$1M$14K
Net Debt-$3M-$1M-$5M-$1M-$5M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms